Question 1

What is the catalog number for Anti-Vaccinia virus-infected A549 cells Aptamer?

Accepted Answer

The catalog number for Anti-Vaccinia virus-infected A549 cells Aptamer is CTMM-0422-MM337.

Question 2

What sizes are available for Anti-Vaccinia virus-infected A549 cells Aptamer?

Accepted Answer

Anti-Vaccinia virus-infected A549 cells Aptamer is available in the following size(s): 10 nmol.

Question 3

Is Anti-Vaccinia virus-infected A549 cells Aptamer in stock?

Accepted Answer

Anti-Vaccinia virus-infected A549 cells Aptamer is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What is Anti-Vaccinia virus-infected A549 cells Aptamer used for?

Accepted Answer

This is a customized product which may need different modifications, such as -NH2, Thiol, Cy3, FAM, AF488 and so on. Usually, we can produce the product within 2 weeks after receiving the PO.

Question 5

What dilution range is recommended for immunohistochemistry (IHC) with this antibody?

Accepted Answer

A starting IHC dilution range is listed on the datasheet, but should be optimized for your specific tissue type and staining protocol.

Question 6

Can I request a Safety Data Sheet (SDS) for this product?

Accepted Answer

Yes, safety data sheets are available for hazardous or chemically classified products and can be provided on request or downloaded from the product page.

Question 7

Can this product be used for co-immunoprecipitation (Co-IP)?

Accepted Answer

Suitability for Co-IP depends on the specific antibody and is noted under validated applications on the datasheet. If it isn’t listed, contact our technical support team for guidance based on your target and sample type.

Anti-Vaccinia virus-infected A549 cells Aptamer

Product Specifications

CAS Number

Format

Storage Conditions

Frequently Asked Questions

Explore Other Products

Myosin, Smooth Muscle Heavy Chain (SMMS-1), CF640R conjugate, 0.1mg/mL

Calcineurin A / PPP3CA (CALNA/2353), CF405S conjugate, 0.1mg/mL

Epstein-Barr Virus (LMP-1) (CS2), CF594 conjugate, 0.1mg/mL

CD44v6 (Marker of Tumor Metastasis) (2F10), 0.2mg/mL

CD2 (LFA2/600), 0.2mg/mL

CD63 (MX-49.129.5), CF405S conjugate, 0.1mg/mL